Loading...
XCSE
CHEMM
Market cap1.36bUSD
Aug 28, Last price  
504.00DKK
Name

Chemometec A/S

Chart & performance

D1W1MN
XCSE:CHEMM chart
P/E
47.05
P/S
17.70
EPS
10.71
Div yield, %
1.39%
Shrs. gr., 5y
0.64%
Rev. gr., 5y
18.28%
Revenues
Net income
CFO
Dividend
Oct 10, 20257 DKK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.
IPO date
Dec 18, 2006
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

No data to show